PhotoniCare
CHAMPAIGN, IL · Healthcare · 9 employees
PhotoniCare was founded out of a shared passion to develop a superior solution for middle ear issues, primarily in children. With $10 billion spent annually to manage ear infections, and a documented 50% misdiagnosis rate for primary care physicians, current tools used to diagnose fluid in the middle ear fail to reliably interpret the patient’s condition. The FDA-cleared OtoSight™ Middle Ear Scope
Funding history
- Series seed — $4.6M — Nov 2024
- Series seed — $4.0M — Dec 2023
- Series seed — $1.1M — May 2023
- Series seed — $1.3M — Aug 2022
- Funding Round — $6.3M — Sep 2020
Recent signals
- Dec 06, 2024: PhotoniCare Raises $4.6M, Establishes Manufacturing Partnership
- Dec 03, 2024: Launched PhotoniCare Inc. Secures $4.6 Million in Series B Financing and Forms Partnership with Gentex Corporation.
- Nov 27, 2024: Raised $4.6M in Series seed
- Dec 14, 2023: Raised $4.0M in Series seed
- May 05, 2023: Raised $1.1M in Series seed
- Aug 04, 2022: Raised $1.3M in Series seed
- Sep 08, 2020: Raised $6.3M
- Aug 19, 2019: Raised $261K in Series seed
See plans & pricing → Track PhotoniCare’s funding, hiring, and signals — with verified contacts — on Fundz.